Clinical Trials | 01 May 2024 | Opinion
What Are the Main Challenges of Modern Clinical Trials?
While the increasing volume of clinical data is welcome in many respects, clinicians and trial managers often ...Read more
Clinical Trials | 01 May 2024 | Opinion
“Regulatory encouragement of advanced tech, including AI will accelerate clinical trials in APAC”
Could you elaborate on the most prominent trends shaping the APAC clinical trials landscape? One of Lokavant&...Read more
BioTech | 01 May 2024 | Opinion
From Hematologic to Autoimmune Disease – The CAR-T Therapy Second Revolution
The Alliance for Regenerative Medicine reported in its January 2024 meeting that, up to 17 regulatory approval...Read more
Clinical Trials | 01 May 2024 | Opinion
How APAC Has Turned into Clinical Trial Behemoth
Over the past decade, the Asia-Pacific (APAC) region has emerged as a global leader in clinical trial conduct....Read more
Singapore | 05 April 2024 | News
Singapore approves new asthma indication for GSK's Trelegy Ellipta
GSK Singapore has announced that the Health Sciences Authority (HSA) has approved a new indication and a new s...Read more
Japan | 29 March 2024 | News
Eisai to divest rights for Merislon and Myonal in Japan to Kaken Pharma for ¥ 3.8 B
Eisai Co. has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment...Read more
China | 19 February 2024 | News
Biocytogen Pharma Beijing and Gilead enter into multi-target antibody collaboration agreement
Biocytogen Pharmaceuticals (Beijing) Co. has announced an antibody evaluation and option agreement with A...Read more
Singapore | 17 April 2024 | News
SCG Cell Therapy and A*STAR launch joint labs for cellular immunotherapies in Singapore
SCG Cell Therapy (SCG) and the Agency for Science, Technology and Research (A*STAR) have announced the launch ...Read more
India | 21 March 2024 | News
Biological E to manufacture oral cholera vaccine for India and global markets
South Korea-based International Vaccine Institute (IVI) has commenced a technology transfer of simplified Oral...Read more
New Zealand | 08 March 2024 | News
Kimer Med inks contract worth NZD $1.3 M to pioneer antiviral drug advances
Kimer Med, a New Zealand (NZ)-based biotech startup, has signed a contract valued at up to $750,000 (NZD$1.3 m...Read more
Korea | 09 April 2024 | News
Korea-based Medit unveils next evolution of Intraoral Scanners
South Korea-based Medit, a leading provider of dental 3D scanners and digital dentistry solutions, has an...Read more
Australia | 02 April 2024 | News
Australia suggests use of ultrasound therapy as promising treatment for Alzheimer’s disease
Australia's University of Queensland (UQ) researchers have found targeting amyloid plaque in the brain is not ...Read more
Europe | 18 March 2024 | News
Korean startup Lunit delivers AI-powered cancer screening solution to France and Portugal
Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therape...Read more
Korea | 21 March 2024 | News
Merck invests € 300+ M in new life science production site in Korea
Merck invests more than €300 million into a new Bioprocessing Production Centre in Daejeon, South Korea. ...Read more
Singapore | 19 March 2024 | News
WuXi Biologics to establish new CRDMO facility in Singapore
China's WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organisation (CRDMO)...Read more
Korea | 09 February 2024 | News
Samsung Biologics & LegoChem Biosciences in Korea team up for ADC development
South Korea-based Samsung Biologics, a global contract development and manufacturing organisation (CDMO), has ...Read more
What’s APAC’s Recipe of Success in CLINICAL TRIALS MARKET?
Asia-Pacific (APAC) is emerging as one of the most promising and resilient markets for clinical trials. According to a report by Clinical Trials Arena, between 2017 and 2022, the region posted growth in clinical trials of around 10 per cent, outstripping growth in other major regions including the US, Europe and the rest of the world (RoW). Asia’s growth far exceeded the overall average figure of 5.3 per cent per year. As of 2023, the number of trials reached 14,346 in APAC. Let's delve into the thriving clinical research landscape in the region and explore the trends driving its growth.